Skip to content

Issues

It’s time for drug chains to shake things up

It’s time for drug chains to shake things up

indeed, three months have passed since the NACDS Total Store Expo gathered the industry together in Boston. Against that background, the NACDS year-end meetings, scheduled for New York City following

WBA works to clear way to finalizing Rite Aid acquisition

WBA works to clear way to finalizing Rite Aid acquisition

Speculation continues to percolate about snags holding up Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. Last last month the New York Post reported that private equity firms were uninterested in purchasing 650 stores that WBA must divest to satisfy antitrust requirements.

Genoa enters New York market

Genoa enters New York market

After opening its 300th pharmacy a few months ago, Genoa has achieved another milestone. The fast-growing behavioral health pharmacy has launched its first location in New York, giving the company 330 pharmacies overall. The new pharmacy is inside the Bay Shore, N.Y.

Chain drug legend Cork Walgreen dies

Chain drug legend Cork Walgreen dies

Charles (Cork) Walgreen III, who led Walgreen Co. for nearly three decades, died last month at age 80. Walgreen, whose grandfather, Charles Walgreen Sr., opened the first Walgreens drug store in Chicago in 1901, was born in 1935 to Mary Ann Leslie and Charles Walgreen Jr. He would go on to become

Former Shoppers Drug Mart leader David Bloom passes

Former Shoppers Drug Mart (SDM) chairman, president and chief executive officer David Bloom died last month at age 73. Bloom, who started with the chain as a pharmacist in 1967, took the reins as president and CEO in 1983.

Young enrollees sought for ACA

Young enrollees sought for ACA

Seeking to boost the number of young people getting health insurance through the Affordable Care Act, the Obama administration is employing targeted digital communications and social ­media.

FMI eliminates its annual trade show

Citing the changing needs of its members, the Food Marketing Institute is cancelling its annual FMI Connect trade show. “FMI aims at all times to be as agile and as bold as required to serve the needs of our members as well as the broader food industry,” said organization president and chief

Walgreens unveils online skin care platform

To help meet the growing need for skin care resources and accessible care and treatment, Walgreens has launched a new skin care answers platform, available through Walgreens.com and the Walgreens mobile app. The average wait time for patients looking to see a dermatologist in the U.S.

Neighbourhood Pharmacies names full-time CEO

The Neighbourhood Pharmacy Association of Canada (Neighbourhood Pharmacies) has appointed Justin Bates as its permanent chief executive officer. Speaking to the appointment, board chair Vivek Sood said: “I am very pleased to announce Justin’s appointment as permanent CEO.

NACDS Foundation taps Seth Meyers as speaker

“Late Night” host and “Saturday Night Live” alumnus Seth Meyers will headline the National Association of Chain Drug Stores Foundation Dinner on December 1 in New York City.

Chain drug retailing loses a pair of icons

Chain drug retailing loses a pair of icons

and, typically of a business that continues to grow, prosper and change, the tendency is to forget to remember what these icons ­accomplished. Last month, two executives who were instrumental in building chain drug retailing passed away. They were radically different, yet remarkably

Brindley: Walgreens is reinventing beauty

Brindley: Walgreens is reinventing beauty

Walgreens’ vision to recreate the beauty shopping experience is becoming a reality at many of its stores. Aiming to be the destination of choice for today’s beauty care consumers, the drug chain will bring its “Beauty Differentiation” concept to about 1,800 stores by end of calendar 2016.

Trump, Clinton part ways on health care policy

Trump, Clinton part ways on health care policy

With the 2016 presidential election drawing near, health care has emerged as a policy area in which the two major candidates’ differences are strikingly clear. A useful starting point might be their respective approaches to prescription drug pricing.